Breaking News

Wednesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
PFE

Pfizer

$36.31

0.3 (0.83%)

, BIIB

Biogen

$287.45

-4.42 (-1.51%)

11:43
02/21/18
02/21
11:43
02/21/18
11:43
Periodicals
Breaking Periodicals news story on Pfizer, Biogen, Roche »

Pfizer loses IPR…

PFE

Pfizer

$36.31

0.3 (0.83%)

BIIB

Biogen

$287.45

-4.42 (-1.51%)

RHHBY

Roche

$29.77

-0.53 (-1.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 08

    Mar

  • 08

    Mar

  • 04

    Apr

  • 30

    May

Over a week ago
RHHBY

Roche

15:27
02/15/18
02/15
15:27
02/15/18
15:27
Hot Stocks
Roche to acquire Flatiron Health in $1.9B deal »

Roche and Flatiron Health…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

  • 30

    May

EXEL

Exelixis

$29.54

0.74 (2.57%)

08:18
02/15/18
02/15
08:18
02/15/18
08:18
Conference/Events
Breaking Conference/Events news story on Exelixis »

FDA PDUFA Date for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

BMY

Bristol-Myers

$65.26

1.39 (2.18%)

, NKTR

Nektar

$75.66

-3.04 (-3.86%)

13:49
02/14/18
02/14
13:49
02/14/18
13:49
Hot Stocks
Nektar jumps after multi-billion-dollar cancer drug pact with Bristol-Meyers »

Shares of Nektar…

BMY

Bristol-Myers

$65.26

1.39 (2.18%)

NKTR

Nektar

$75.66

-3.04 (-3.86%)

RHHBY

Roche

$29.26

0.04 (0.14%)

MRK

Merck

$54.95

0.05 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 14

    Feb

  • 14

    Feb

  • 23

    Feb

  • 26

    Feb

  • 05

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 04

    Apr

  • 23

    Apr

  • 03

    May

  • 30

    May

  • 23

    Oct

RHHBY

Roche

$29.26

0.04 (0.14%)

05:24
02/14/18
02/14
05:24
02/14/18
05:24
Hot Stocks
Genentech Rituxan granted FDA priority review »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 23

    Feb

  • 30

    May

RHHBY

Roche

$29.26

0.04 (0.14%)

04:55
02/14/18
02/14
04:55
02/14/18
04:55
Conference/Events
Roche management to meet with JPMorgan »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 23

    Feb

  • 30

    May

EXEL

Exelixis

$28.80

-0.25 (-0.86%)

16:09
02/13/18
02/13
16:09
02/13/18
16:09
Hot Stocks
Exelixis says cabozantinib study showed 'encouraging' efficacy »

Exelixis announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 15

    Feb

RHHBY

Roche

$29.22

0.24 (0.83%)

14:08
02/13/18
02/13
14:08
02/13/18
14:08
Hot Stocks
Roche receives FDA clearance for cobas Factor II, Factor V Test »

Roche announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 14

    Feb

  • 23

    Feb

  • 30

    May

RHHBY

Roche

$29.22

0.24 (0.83%)

09:50
02/13/18
02/13
09:50
02/13/18
09:50
Conference/Events
Genentech to hold a conference call »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 14

    Feb

  • 23

    Feb

  • 30

    May

RHHBY

Roche

$29.22

0.24 (0.83%)

07:48
02/13/18
02/13
07:48
02/13/18
07:48
Conference/Events
Genentech to hold a conference call »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

  • 23

    Feb

  • 30

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.